All Stories

  1. Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, April 2019, Taylor & Francis

    Ruggero Dittadi, Massimo Gion

  2. Evaluation of the possible interference of abiraterone therapy on testosterone immunoassay

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2019, De Gruyter

    Ruggero Dittadi

  3. The challenge of the reference intervals determination: An example from two articles published in the present issue

    Article • The International Journal of Biological Markers, November 2018, SAGE Publications

    Ruggero Dittadi

  4. Epidemiology-Based Assessment of Tumor Marker Overordering in Breast Cancer: An Algorithm to Examine Different Disease Conditions

    Article • The International Journal of Biological Markers, October 2017, SAGE Publications

    Ruggero Dittadi, Massimo Gion

  5. Reassessment of the Access Testosterone chemiluminescence assay and comparison with LC-MS method

    Article • Journal of Clinical Laboratory Analysis, June 2017, Wiley

    Ruggero Dittadi

  6. Multicenter evaluation of the new immunoassay method for TSH measurement using the automated DxI platform

    Article • Clinica Chimica Acta, May 2017, Elsevier

    Ruggero Dittadi

  7. Harmonization protocols for TSH immunoassays: a multicenter study in Italy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2017, De Gruyter

    Ruggero Dittadi, Aldo Clerico

  8. Evaluation of serum cortisol biological variation in the evening withdrawal

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2017, De Gruyter

    Ruggero Dittadi

  9. Analytical quality requirements in the IgE specific assay

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Ruggero Dittadi

  10. Evaluation of a sex hormone-binding globulin automated chemiluminescent assay

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2013, Taylor & Francis

    Ruggero Dittadi

  11. Re: Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase

    Article • Clinical Biochemistry, August 2013, Elsevier

    Ruggero Dittadi

  12. Evaluation of an ELISA method for the measurement of chromogranin A and comparison with an immunoradiometric method

    Article • The International Journal of Biological Markers, September 2012, Wichtig

    Ruggero Dittadi

  13. Within-subject biological variation in disease: the case of tumour markers

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, March 2008, SAGE Publications

    Ruggero Dittadi

  14. Biological variability evaluation and comparison of three different methods for C-peptide measurement

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2008, De Gruyter

    Ruggero Dittadi

  15. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2007, De Gruyter

    Ruggero Dittadi

  16. Biological variation of vascular endothelial growth factor

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2005, De Gruyter

    Ruggero Dittadi

  17. Biological variation of plasma chromogranin A

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2004, De Gruyter

    Ruggero Dittadi

  18. c-erbB2 Expression in Breast Tumors

    Article • JNCI Journal of the National Cancer Institute, September 2000, Oxford University Press (OUP)

    Ruggero Dittadi

  19. How CA 125 Is Used in the Routine Follow-Up of Ovarian Cancer:A Survey of 29 Italian Hospitals

    Article • Tumor Biology, January 1998, Springer Science + Business Media

    Ruggero Dittadi

  20. Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue

    Article • British Journal of Cancer, January 1993, Nature

    Ruggero Dittadi

  21. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue

    Article • British Journal of Cancer, October 1991, Nature

    Ruggero Dittadi

  22. Relationship between Receptor Status and Cytosol Levels of E1, E2, E3and DHAS in Breast Carcinoma

    Article • Annals of the New York Academy of Sciences, June 1986, Wiley

    Ruggero Dittadi

  23. 58 Determination of E1, E2, E3 and DHAS in the tissue of breast carcinoma: Relationships with receptor status

    Article • Journal of Steroid Biochemistry, January 1985, Elsevier

    Ruggero Dittadi